Element Capital Management LLC Amgen Inc Transaction History

Element Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $668,366 - $743,775	2,897 Added 50.01%	8,690 $2.11 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $1.27 Million - $1.41 Million	5,793 New	5,793 $1.4 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $4.06 Million - $4.76 Million	-24,336 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $11.4 Million - $12.9 Million	-63,255 Reduced 72.22%	24,336 $4.62 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $1.88 Million - $2.19 Million	10,520 Added 13.65%	87,591 $17.1 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $10.2 Million - $11.5 Million	54,973 Added 248.77%	77,071 $16 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $25.1 Million - $28.2 Million	-150,987 Reduced 87.23%	22,098 $4.08 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $29.3 Million - $34.3 Million	173,085 New	173,085 $29.5 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.